Recession and income inequality have fuelled HIV infections in European drug users

Georgios Nikolopoulos, of the University of Athens, presenting at AIDS 2014. Image by Roger Pebody (
Roger Pebody
Published: 21 July 2014

In European countries, increases in rates of reported HIV infections among people who inject drugs in recent years have been associated with the economic downturn and income inequality, Georgios Nikolopoulos of the University of Athens told the 20th International AIDS Conference (AIDS 2014) in Melbourne today.

In most European countries, HIV infection rates in people who inject drugs have been stable or have declined over the past decade. However, Greece and Romania experienced an almost 20-fold increase in new diagnoses between 2010 and 2012. It has been suggested, but not proven, that these outbreaks were caused by the economic crisis that began in 2007, with cuts to harm reduction services possibly being a crucial factor.

There is limited quantitative evidence on the associations between economic problems and HIV infections, especially in a pan-European context. The researchers therefore examined data from 30 different European countries, collecting national statistics from a ten-year period (2003-2012) on:

  • economic indicators (GDP per capita, GDP growth, income inequality, poverty, unemployment, etc.),
  • services and policies (government expenditure on health and social programmes, numbers receiving opioid substitution therapy, availability of needle and syringe programmes, etc.), and
  • drug use (number of people who inject drugs, number using opiods, etc.).

Dr Nikolopoulos and colleagues examined the associations of these factors with periods of time in which specific countries had experienced significant increases in the HIV diagnosis rate among people who inject drugs. As well as the dramatic outbreaks in Greece and Romania, a number of other countries had experienced smaller rises and spikes in infection during the ten-year period.

He used “lagged values” – in other words, considering the possibility that economic problems or a cut in harm reduction services would only have an impact on HIV diagnoses one, two or three years later. The figures below are based on an assumption of a two-year lag between economic effects and health impact, but similar results were produced if a one- or two-year lag were assumed.

Even in the first (univariable) analysis, the only factors significantly associated with increases in HIV infections were economic: the GDP growth rate, poverty and three separate measures of income inequality (S80/S20, Gini-coefficient and the Public Wealth Index).

And in multivariable analysis, after adjusting for confounding factors, only two factors were significantly associated with an increase in diagnoses. Firstly, countries with continued growth in GDP were less likely to have rises in HIV diagnoses (odds ratio 0.65, 95% confidence interval 0.48-0.86). Secondly, countries with a higher Gini-coeffecient (income inequality) were more likely to have more diagnoses (odds ratio 1.49, 95% CI: 1.00-2.22).

Put more simply, countries in economic recession or with greater income inequality were more likely to have jumps in HIV infections in people who inject drugs.

Presenting the data, Georgios Nikolopoulos noted numerous other examples of economic crises, conflicts and other social upheavals having an impact on health. Several studies have found evidence of worse infectious disease outcomes during recession, often as a result of higher rates of infectious contact in poor living circumstances, worse access to therapy, or poor retention in care. When the Soviet Union broke up, the subsequent economic crisis and collapse of existing social structures was associated with massive increases in HIV and TB infections, alongside other health problems. Globally, countries with worse income inequality have higher prevalence of HIV.

He commented that the mechanisms through which economic problems lead to infections remain unclear, but it is unlikely to be entirely due to less provision of harm reduction services – in many settings, very few services were available even before the recession.

He concluded that governments should be aware that they could help avert HIV epidemics in people who inject drugs through economic policies that assure economic growth and a more equal distribution of a country's wealth.


Nikolopoulos G et al. Recession and income inequality are associated with large increases in rates of reported HIV infections among people who inject drugs in Europe. 20th International AIDS Conference, Melbourne, abstract MOAD0104, 2014.

View the abstract on the conference website.

NAM’s AIDS 2014 bulletins have been made possible thanks to support from Bristol-Myers Squibb. NAM's wider conference news reporting services have been supported by AbbVie, Gilead Sciences, Janssen and ViiV Healthcare’s Positive Action Programme.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.